We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Strip-Type Urine Sensor Diagnoses Cancer Quickly and With High Sensitivity

By LabMedica International staff writers
Posted on 15 Feb 2023

Various blood tests, radiological methods and histological analysis are currently used to diagnose cancer. More...

Annual health checkups can also reveal the presence of cancer, although the disease is mostly detected after it has advanced considerably, resulting in delayed treatment or death. Now, a research team has developed a strip-type urine sensor that can amplify the light signal of metabolites in urine to help diagnose cancer.

The technology developed by researchers at Korea Institute of Materials Science (KIMS, Gyeongsangnam-do, South Korea) could find application in screening for prostate cancer and pancreatic cancer by irradiating light using a small volume (10uL) of urine taken at the time of the test without the need for any additional analysis process. The test device is in the form of a strip that allows cancer to be diagnosed quickly and with high sensitivity. As a biological sample, urine can be easily obtained, making the test more accessible. The urine-based diagnosis method could be used for on-site rapid cancer screening or as recurrence monitoring technology following treatment of cancer patients. Additionally, the strip-type sensor has a low manufacturing cost that will allow it to be used for mass consumption.

The research team developed the strip-type sensor by focusing on the metabolomic components present in the urine of cancer patients and normal people. In cancer patients, proliferating cancer cells secrete various metabolites into urine owing to abnormal metabolism. Classifying these metabolites in urine using existing technology requires large and expensive equipment, thus limiting its on-site application. In order to overcome this challenge, the researchers developed a surface-enhanced Raman scattering sensor that amplifies the optical signal of metabolites in urine by more than one billion times. When the urine sample is dropped into the sensor and light is irradiated, the cancer metabolite signals tend to become amplified on the surface of the sensor, enabling the diagnosis of cancer. Upon applying an artificial intelligence (AI)-based analysis method to the acquired spectral signal, the researchers were able to identify up to 99% of prostate cancer and pancreatic cancer patients.

“In the case of cancers where the diagnosis method is not well known, such as pancreatic cancer, it is difficult to detect and the survival rate after initial diagnosis is low,” said Dr. Ho Sang Jung of the Surface & Nano Materials Division of KIMS, a senior researcher in charge of the research. “Since early diagnosis is the most important for incurable diseases such as cancer, we expect this technology to provide a new diagnostic method.”

Related Links:
KIMS


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
STI Test
REALQUALITY RQ-SevenSTI
New
Biochemistry Analyzer
Chemi+ 8100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Gut microbes may help in recognizing and treating pancreatic cancer (Photo courtesy of Adobe Stock)

Gut Microbes Could Enable Early Detection and Treatment of Pancreatic Cancer

Pancreatic cancer remains one of the most serious and challenging diseases in oncology due to its difficulty in detection and limited treatment options. Now, a new international collaborative study suggests... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Microbiology

view channel
Image: The U.S. FDA-cleared IntelliSep rapid host response diagnostic represents a breakthrough in sepsis care (Photo courtesy of Cytovale)

Rapid Diagnostic Test Slashes Sepsis Mortality by 39%

Sepsis remains one of the most challenging and fatal conditions in contemporary healthcare, accounting for nearly one-third of all hospital-related deaths in the United States. In emergency departments... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.